Northern Trust’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-626,019
Closed -$29.7M 4453
2025
Q3
$29.7M Sell
626,019
-8,307
-1% -$402K ﹤0.01% 1438
2025
Q2
$33.8M Sell
634,326
-22,407
-3% -$1.02M ﹤0.01% 1326
2025
Q1
$26.6M Buy
656,733
+36,412
+6% +$1.54M ﹤0.01% 1462
2024
Q4
$17.3M Buy
620,321
+35,737
+6% +$1.08M ﹤0.01% 1790
2024
Q3
$16.8M Sell
584,584
-3,282
-0.6% -$85.6K ﹤0.01% 1737
2024
Q2
$13.8M Sell
587,866
-9,822
-2% -$210K ﹤0.01% 1807
2024
Q1
$15.1M Buy
597,688
+57,003
+11% +$1.37M ﹤0.01% 1791
2023
Q4
$12.6M Buy
540,685
+2,662
+0.5% +$52.5K ﹤0.01% 1911
2023
Q3
$27.2M Buy
538,023
+77,594
+17% +$3.61M 0.01% 1336
2023
Q2
$21.5M Buy
460,429
+102,662
+29% +$4.7M ﹤0.01% 1535
2023
Q1
$13.7M Sell
357,767
-2,510
-0.7% -$112K ﹤0.01% 1807
2022
Q4
$19.7M Buy
360,277
+95,767
+36% +$4.1M ﹤0.01% 1528
2022
Q3
$9.01M Buy
264,510
+20,232
+8% +$310K ﹤0.01% 2051
2022
Q2
$2.31M Buy
244,278
+8,353
+4% +$87.1K ﹤0.01% 2977
2022
Q1
$3.35M Sell
235,925
-13,849
-6% -$242K ﹤0.01% 2819
2021
Q4
$5.28M Buy
249,774
+2,831
+1% +$62.8K ﹤0.01% 2640
2021
Q3
$5.52M Sell
246,943
-10,069
-4% -$228K ﹤0.01% 2661
2021
Q2
$6.38M Buy
257,012
+83,012
+48% +$2.33M ﹤0.01% 2696
2021
Q1
$5.05M Sell
174,000
-12,968
-7% -$393K ﹤0.01% 2735
2020
Q4
$4.82M Sell
186,968
-5,116
-3% -$142K ﹤0.01% 2706
2020
Q3
$5.91M Buy
192,084
+38,032
+25% +$1.33M ﹤0.01% 2421
2020
Q2
$3.84M Buy
154,052
+54,190
+54% +$1.24M ﹤0.01% 2678
2020
Q1
$2.12M Buy
99,862
+30,701
+44% +$658K ﹤0.01% 2824
2019
Q4
$1.53M Sell
69,161
-775
-1% -$16K ﹤0.01% 3246
2019
Q3
$1.59M Buy
69,936
+58,608
+517% +$1.36M ﹤0.01% 3224
2019
Q2
$217K Buy
+11,328
New +$215K ﹤0.01% 3800

Other funds holding AKRO